Agilent Technologies ... and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the ...

Agilent makes more capillary columns than anyone else in the world and our commitment to product reliability and repeatability has raised the level of quality that chromatographers demand.

Since 1999, one of the more popular manufacturers of test equipment has been Agilent, the spun-off former instrument division of Hewlett-Packard. From simple multimeters to fully-equipped ...

Shares of Agilent Technologies Inc. A inched 0.46% higher to $134.28 Wednesday, on what proved to be an all-around great ...

Shares of Agilent Technologies Inc. A slumped 0.90% to $130.31 Thursday, on what proved to be an all-around poor trading ...

Agilent’s latest product offerings in the LSAG segment are expected to drive top-line growth. A’s introduction of an advanced gas chromatography/mass spectrometry (GC/MS) column technology ...

On Monday, Agilent Technologies Inc (A) stock saw a decline, ending the day at $133.86 which represents a decrease of $-2.82 or -2.06% from the prior close of $136.68. The stock opened at $137.2 and ...

Citi analyst Patrick B Donnelly maintained a Buy rating on Agilent (A – Research Report) today and set a price target of $165.00. The company’s shares closed last Friday at $143.82.

SANTA CLARA, Calif., October 16, 2024--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the fourth quarter of fiscal year 2024 after the stock market closes ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The DB-1301 is a low- to mid- polarity column. Agilent makes more capillary columns than anyone else in the world and our commitment to product reliability and repeatability has raised the level ...

Telehealth company Ro has rolled out a new tool to track the supply of weight loss drugs like Ozempic and Wegovy across the U.S., as patients struggle with shortages. Novo Nordisk has been slowly ...